Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875

b3cnewswireAugust 22, 2020

Tag: Byondis , antibody-drug , Conjugate SYD1875

PharmaSources Customer Service